If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

Correction - Director/PDMR Sh

1 Aug 2008 11:43

RNS Number : 4583A
K3 Business Technology Group PLC
01 August 2008
 

K3 Business Technology Group plc ("K3" or the "Company")

Director dealing - correction

This announcement corrects the announcement made on 5 June 2008, RNS Number : 0434W, in which Mr Johan Claesson's holding in the Company was incorrectly disclosed. The correct text appears below.

K3 announces that the Subscription Period for Warrants issued pursuant to a Warrant Instrument dated 23 June 2005 entitling Johan Och Marianne Claesson AB, a Swedish company associated with Mr Johan Claesson (a non-executive director of the Company) to subscribe for 400,000 ordinary shares in the capital of the Company at a price per share of 90 pence has today been extended from 22 June 2008 to expire on 31 December 2008. All other terms of the Warrants remain unaltered.

The extension to the Subscription Period has been made in recognition of the continuing variation of loan repayment terms by CA Fastigheter AB, a company associated with Mr Claesson 

Mr Claesson holds 4,001,448 ordinary shares of 25 pence each in the capital of the Company. - ENDS -

 

 

For further information:

K3 Business Technology Group plc:

David Bolton, Chief Finance Officer +44 (0) 1282 864 111

Daniel Stewart & Company Plc

Paul Shackleton +44 (0) 20 7776 6550

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUUUMWRUPRGUG
Date   Source Headline
29th Nov 20215:36 pmRNSDirector/PDMR Shareholding
22nd Nov 20214:43 pmRNSPDMR Announcement
15th Nov 20212:30 pmRNSDirector/PDMR Shareholding
10th Nov 20215:06 pmRNSPDMR Announcement
18th Oct 202112:48 pmRNSPDMR Announcement
4th Oct 20213:00 pmRNSPDMR Announcement
27th Sep 20212:03 pmRNSPDMR Announcement
22nd Sep 202111:02 amRNSPDMR Announcement
20th Sep 20217:00 amRNSSale of Sage Business for £1.68m cash
26th Jul 20217:00 amRNSInterim Results
1st Jul 202111:37 amRNSHolding(s) in Company
21st Jun 20214:00 pmRNSPDMR Announcement
18th Jun 20214:54 pmRNSMarket Price Share Option Scheme
14th Jun 20218:08 amRNSPDMR Announcement
2nd Jun 202111:45 amRNSHolding(s) in Company
1st Jun 202110:46 amRNSPDMR Announcement
19th May 20211:30 pmRNSResult of AGM
12th May 20215:57 pmRNSDirector/PDMR Share Purchase
5th May 20211:43 pmRNSPDMR Announcement
4th May 20212:52 pmRNSDirector/PDMR Share Purchase
23rd Apr 20217:00 amRNSNotice of AGM and Posting of Annual Report
9th Apr 20212:49 pmRNSHolding(s) in Company
9th Apr 20212:47 pmRNSHolding(s) in Company
9th Apr 20212:46 pmRNSHolding(s) in Company
6th Apr 20214:59 pmRNSPDMR Announcement
30th Mar 20217:30 amRNSLong Term Incentive Plan Option Scheme
30th Mar 20217:30 amRNSShareholder Loan Conversion
30th Mar 20217:00 amRNSFinal Results
30th Mar 20217:00 amRNSAppointment of Chief Executive Officer
5th Mar 20217:00 amRNSBoard Change
1st Mar 20213:54 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSSale of subsidiary
13th Nov 20207:00 amRNSLong Term Incentive Plan
12th Nov 20207:00 amRNSPDMR Announcement
2nd Nov 20207:00 amRNSTrading Update
28th Oct 20207:00 amRNSAppointment of Chairman
28th Aug 202011:05 amRNSResult of General Meeting
12th Aug 20207:57 amRNSPDMR Announcement
11th Aug 20204:41 pmRNSSecond Price Monitoring Extn
11th Aug 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20204:03 pmRNSPDMR Announcement
4th Aug 20207:00 amRNSInterim Results
29th Jul 20205:25 pmRNSNotice of General Meeting & Posting Annual Report
27th Jul 20207:00 amRNSFinal Results
15th Jul 20203:15 pmRNSNotice of Results
22nd Jun 20207:00 amRNSNotice of Results
29th May 202012:11 pmRNSResult of AGM
29th May 20207:00 amRNSAGM and Notice of Results
5th May 20209:47 amRNSNotice of AGM
3rd Apr 20205:08 pmRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.